Influenza nucleic acid molecules and vaccines made therefrom
US-9192660-B2 · Nov 24, 2015 · US
Agent for ameliorating brain hypofunction
US8987232B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8987232-B2 |
| Application number | US-201113035717-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 25, 2011 |
| Priority date | Sep 4, 2008 |
| Publication date | Mar 24, 2015 |
| Grant date | Mar 24, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Provided are effective and highly safe agents, medicaments and the like for ameliorating various disorders caused by brain hypofunction. Also provided is a preventing or ameliorating agent for brain hypofunction containing N-acetyl-D-mannosamine, a pharmaceutical composition for preventing, ameliorating or treating disorders due to brain hypofunction, containing an effective amount of N-acetyl-D-mannosamine and a pharmaceutically acceptable carrier, and a food comprising N-acetyl-D-mannosamine added thereto.
First claim
Opening claim text (preview).
The invention claimed is: 1. A method of ameliorating or treating a sleep interruption due to premature arousal in a subject in need thereof, comprising administering an effective amount of N-acetyl-D-mannosamine to the subject. 2. A method of ameliorating a sleep interruption due to premature arousal in a subject in need thereof, comprising allowing an effective amount of N-acetyl-D-mannosamine to be taken by the subject. 3. The method of c…
Assignees
Inventors
Classifications
Human Necessities · mapped topic
- A61K31/7008Primary
Human Necessities · mapped topic
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US8987232B2 cover?
- Provided are effective and highly safe agents, medicaments and the like for ameliorating various disorders caused by brain hypofunction. Also provided is a preventing or ameliorating agent for brain hypofunction containing N-acetyl-D-mannosamine, a pharmaceutical composition for preventing, ameliorating or treating disorders due to brain hypofunction, containing an effective amount of N-acetyl-…
- Who is the assignee on this patent?
- Shiota Kunio, Kuwahara Masayoshi, Kikusui Takefumi, and 3 more
- What technology area does this patent fall under?
- Primary CPC classification A61K31/7008. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).